THIS WEEK'S FEATURE
After recently conducting five first-in-man coronary stent procedures robotically in India, Corindus Vascular Robotics (NASDAQ:CVRS) plans to perform its first remote vascular cases in the U.S. in mid-2019, leading to a potential product launch in 2020.
Closely-held DxTerity has developed the first affordable diagnostics platform for at-home monitoring of autoimmune disease activity and response to drug treatment, with tests that use longitudinal gene expression data obtained from biological samples taken from the same subject at different time points.
As a principal of closely-held MIDI Medical Product Development, Greg Montalbano has a unique background in industrial design, usability/ergonomics and manufacturing with over 25 years of experience developing products for medical, life sciences and home healthcare markets.
Closely-held PharmaJet’s needle-free injection devices have the potential to rapidly improve the delivery of vaccines in emerging markets as well as pharmaceuticals currently under development.
Closely-held Lineagen has developed and commercialized a comprehensive portfolio of behavioral screening and genetic tests for autism spectrum disorders (ASD) and other forms of childhood neurodevelopmental disorders (NDDs).